Why did Intuitive Surgical agree to merge with Computer Motion?

According to the filing, the board believed the companies' technologies were complementary, that the merger would end costly patent litigation and remove the risk of an adverse infringement ruling, and that combining operations could yield about $18 million in annual pre-tax cost savings starting in late 2003. Both companies had been losing money, and Computer Motion had limited cash, so the combination also addresses the pressure on the smaller rival.

How much cash does Intuitive Surgical have, and is it enough?

Intuitive ended 2002 with $50.8 million in cash, cash equivalents and short-term investments, down from $66.7 million a year earlier, and it burned $14.1 million in operating cash flow. Management says current balances plus product revenue should cover liquidity needs at least through 2003. Beyond that, the company may need to raise equity or debt, which could dilute shareholders. Management projects the combined company will hold less than $35 million in cash after the merger closes.

What are the biggest legal risks to the business?

The most material matter is the Wilk patent suit, where the Federal Circuit reversed the lower court's noninfringement ruling in April 2003 and the case returns for further proceedings. Computer Motion's suit over ten robotic-surgery patents is stayed until August 31, 2003 but could resume if the merger fails, and it seeks damages (including treble damages) and possibly an injunction against the da Vinci system. The company says it has meritorious defenses, but the filing states it cannot predict outcomes or estimate potential losses.

What drives Intuitive Surgical's revenue and what limits growth?

Revenue depends mainly on sales of da Vinci systems, which are high-priced capital items with lengthy purchase cycles requiring senior management approval at hospitals, so quarterly results can swing widely. Recurring revenue from EndoWrist instruments and service is a growing share as installed systems accumulate. Growth is limited by surgeon training requirements, the need for FDA clearance of new procedures, uncertain third-party reimbursement for robotic procedures, and competition from established minimally invasive and open surgery techniques.

How would the merger affect existing Intuitive Surgical shareholders?

Current shareholders would own about 72% of the combined company and former Computer Motion holders about 28%, based on the estimated exchange ratio of roughly 0.48 to 0.52 Intuitive shares per Computer Motion share. The filing notes approximately 5.2 to 5.7 million additional shares would be reserved for assumed Computer Motion options and warrants, and some warrants carry anti-dilution protection. Because the deal is share-based, existing holders face reduced percentage ownership in earnings, voting and liquidation value, and the deal could fail to close by August 31, 2003.

ISRG 10-K FY2002 Annual Report — Revenue, Net Income, EPS

01—Abstract

Summary

Summary of the 10-K/A filed May 9, 2003. Cited figures are marked; the original filing is the authoritative source.

Intuitive Surgical's 2002 10-K (filed May 9, 2003) shows a company still in early commercialization of the da Vinci Surgical System.

Sales grew 39% to $72.0 million^a in 2002, driven by 60 system placements (versus 49 in 2001) and recurring instrument, accessory and service revenue, which rose 116% to $15.1 million and reached 21% of sales. Gross margin improved to 52% from 45%, but the company still lost $18.4 million for the year, with operating loss essentially flat at $20.2 million despite the revenue growth, because SG&A rose 36% and R&D rose 21%. Cash, equivalents and short-term investments fell to $50.8 million from $66.7 million, and management expects liquidity to be sufficient only through 2003 absent additional financing.

The dominant event in the filing is the pending all-stock merger with rival Computer Motion, announced March 7, 2003. Intuitive expects to issue about 14.7 million shares, leaving its current holders with roughly 72% of the combined company. Management projects about $18 million^b in annual pre-tax cost savings from late 2003, largely from headcount reductions.

Intuitive also agreed to bridge-loan up to $7.3 million^c to Computer Motion, which itself reported a $21.2 million 2002 net loss and only $2.6 million in cash. Pending patent litigation between the two companies has been stayed through August 31, 2003 pending closing.

Investors should weigh several risks: continued losses, dependence on high-priced capital equipment with long sales cycles, a Wilk patent appeal that was reversed in April 2003, unresolved Computer Motion patent claims (including a $4.4 million^d jury verdict in Intuitive's favor on a separate IBM-licensed patent), and the merger's dilution and integration risk. Reimbursement for newer procedures and the need for FDA clearance of additional indications also remain open items.

02—Key points

Key Highlights

Sales rose 39% to $72.0 million in 2002, with 60 da Vinci systems sold (up from 49) and cumulative placements reaching 149.
Gross margin improved to 52% of sales from 45% in 2001, driven by higher average system selling price ($948,000) and better manufacturing and service efficiency.
Recurring instrument, accessory and service revenue grew 116% to $15.1 million, rising to 21% of total sales from 14% in 2001.
Net loss narrowed slightly to $18.4 million ($0.51 per share) from $16.7 million, but the company is still unprofitable and operating expenses grew faster than gross profit.
Pending merger with Computer Motion would issue about 14.7 million shares, giving current Intuitive holders about 72% ownership; management targets $18 million in annual pre-tax cost savings starting late 2003.
Cash and short-term investments declined to $50.8 million from $66.7 million; management says resources are sufficient only through 2003 without additional financing.
Significant litigation exposure remains, including patent suits with Computer Motion and Brookhill-Wilk 1, with the Wilk appeal reversed on April 11, 2003 and the Computer Motion actions stayed through August 31, 2003.

03—Questions

Frequently Asked Questions

Why did Intuitive Surgical agree to merge with Computer Motion?
According to the filing, the board believed the companies' technologies were complementary, that the merger would end costly patent litigation and remove the risk of an adverse infringement ruling, and that combining operations could yield about $18 million in annual pre-tax cost savings starting in late 2003. Both companies had been losing money, and Computer Motion had limited cash, so the combination also addresses the pressure on the smaller rival.
How much cash does Intuitive Surgical have, and is it enough?
Intuitive ended 2002 with $50.8 million in cash, cash equivalents and short-term investments, down from $66.7 million a year earlier, and it burned $14.1 million in operating cash flow. Management says current balances plus product revenue should cover liquidity needs at least through 2003. Beyond that, the company may need to raise equity or debt, which could dilute shareholders. Management projects the combined company will hold less than $35 million in cash after the merger closes.
What are the biggest legal risks to the business?
The most material matter is the Wilk patent suit, where the Federal Circuit reversed the lower court's noninfringement ruling in April 2003 and the case returns for further proceedings. Computer Motion's suit over ten robotic-surgery patents is stayed until August 31, 2003 but could resume if the merger fails, and it seeks damages (including treble damages) and possibly an injunction against the da Vinci system. The company says it has meritorious defenses, but the filing states it cannot predict outcomes or estimate potential losses.
What drives Intuitive Surgical's revenue and what limits growth?
Revenue depends mainly on sales of da Vinci systems, which are high-priced capital items with lengthy purchase cycles requiring senior management approval at hospitals, so quarterly results can swing widely. Recurring revenue from EndoWrist instruments and service is a growing share as installed systems accumulate. Growth is limited by surgeon training requirements, the need for FDA clearance of new procedures, uncertain third-party reimbursement for robotic procedures, and competition from established minimally invasive and open surgery techniques.
How would the merger affect existing Intuitive Surgical shareholders?
Current shareholders would own about 72% of the combined company and former Computer Motion holders about 28%, based on the estimated exchange ratio of roughly 0.48 to 0.52 Intuitive shares per Computer Motion share. The filing notes approximately 5.2 to 5.7 million additional shares would be reserved for assumed Computer Motion options and warrants, and some warrants carry anti-dilution protection. Because the deal is share-based, existing holders face reduced percentage ownership in earnings, voting and liquidation value, and the deal could fail to close by August 31, 2003.

04—Continue

← View all 10-K filings